Hashemi and Almarzooqi cofounded Metabolic in 2019 (formerly GluCare.Health), a hybrid metabolic health platform. In February 2026, it secured a growth capital facility from RAKBANK. The company partners with Novo Nordisk, Eli Lilly, Dexcom, Roche, and Medtronic on therapeutic launches, clinical research and diagnostics. It has also published over 50 peer-reviewed clinical studies to date on its care model. It operates three clinics in Dubai, with a London clinic planned for Q4 2026 and US expansion planned for 2027. Hashemi previously founded Amana Healthcare, which was acquired by Mubadala in 2019. Almarzooqi previously served as deputy head at Mubadala Healthcare.